 Treatments differ according to type of amyloidosis present.For light-chain amyloidosis, the use of FLC assays and NT-proBNP levels can be used to monitor the progression of amyloidosis and any response to treatments.Treatments targeting plasma cells to eliminate the misfolded free light chains can be done, such as chemotherapy for amyloidogenic plasma cell dyscrasia.